Kheiron partners with Hospital Services Limited

To bring AI – enabled breast screening solution Mia to breast screen programmes across Ireland

Marking a new milestone for artificial intelligence (AI) adoption in the breast screening community across the Island of Ireland, United Kingdom-based Kheiron Medical Technologies has engaged with Hospital Services Limited (HSL) to bring the Mia® solution to the Health Services in Northern Ireland and the Republic of Ireland. As the first and only solution of its kind with CE regulatory clearance for use as an AI-enabled independent reader for the early detection of breast cancer, Mia is being launched in partnership with specialist medical supplies distributor HSL, an Island-of-Ireland based company focused on bringing market-leading healthcare technology products and solutions to public and private hospitals in the UK and Ireland.

“Our mission at Kheiron is to support breast screening professionals in the fight against breast cancer with proven and effective AI-enabled tools,” states Alex Hamlow, Kheiron’s Chief Commercial Officer.  “We’re excited that Mia is the first AI independent reader solution available for use within the breast screening community across the Island of Ireland.  Based on its performance in the UK and Europe, Mia represents a major breakthrough in helping radiologists to dramatically improve breast cancer detection and patient outcomes.”

“According to Breast Cancer Ireland, 690 deaths are attributed to breast cancer annually in the Republic of Ireland and 3,700 women in Ireland are diagnosed every year with breast cancer. In our meetings with radiologists and breast screening programme leaders across Ireland, we’ve had the opportunity to discuss how AI and Mia can help both radiologists and the women they care for,” Mr Hamlow continued.

With patented AI technology developed on more than three million breast images, Mia (Mammography Intelligent Assessment) is designed to support breast radiologists in deciding whether to recall women for further testing based on their mammography screening.  It was created to deliver gold standard double-reading quality with a single human reader and can also function as an independent second reader, a concurrent reader, or in double reader triage. 

“We are looking forward to bringing the Mia solution to the breast screening community throughout Ireland,” comments Dominic Walsh, HSL’s Chief Executive Officer. “It has tremendous potential to transform the breast screening pathway by empowering breast screening professionals to detect potential malignancies more accurately and quickly, ultimately saving more lives in the fight against breast cancer.”

Mia’s effectiveness has been proven in one of the most ambitious clinical studies in radiology AI to date, which evaluated Mia as an independent reader of mammograms and as a triaging solution. This ground-breaking study tested Mia across more than 275,000 cases from seven sites in the UK and Hungary. In addition, Kheiron was one of the recipients of the UK Government’s first AI in Health and Care Awards through which Mia is undergoing multiple deployments and clinical studies across 15 sites as a benchmark for how to integrate new, cutting-edge technologies into the NHS safely and effectively. 

Latest articles

PR

11th May 2022

Kheiron Forms US Breast Medical Advisory Board; Appoints Three Leaders With Deep Track Record Advocating For Women’s Health

Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel are trailblazers at the forefront of introducing innovative breast imaging technologies into clinical practice (London ...

Read more
Latest articles

PR

4th May 2022

InHealth signs up to AI Award with Kheiron

InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in...

Read more
Latest articles

PR

9th March 2022

Kheiron included in Fast Company’s Most Innovative Companies 2022 list

This AI cancer diagnostics company joins the ranks of Canva, Microsoft, SpaceX, and other winning companies that are changing lives for the better (London –  March 9, 20...

Read more
Latest articles

PR

30th November 2021

Dr Ben Glocker Joins Kheiron

As Head of Machine Learning Research, Glocker will help make sure that Kheiron’s algorithms generalize and can help patients, regardless of their ethnic background or where they ...

Read more
Latest articles

PR

29th November 2021

Kheiron Introduces RSViP to U.S.

AI-Enabled Scheduling Tool That Focuses Attention on Women Who Need Breast Screening the Most Nov. 29, 2021 – As many as 3.9 million women in the U.S. missed their routine ma...

Read more
Latest articles

PR

29th November 2021

Stanford University Partners with Kheiron

Collaboration leverages Stanford’s clinical expertise and Kheiron’s machine learning capabilities to assist radiologists in more effectively staging and monitoring treatment re...

Read more
Latest articles

PR

29th November 2021

Kheiron Introduces Mia IQ to U.S.

Award-Winning AI Solutions Developer Launches Image Quality Assurance Tool to Support Radiographers and Radiologists in Breast Screening Process Nov. 29, 2021 – To aid breast...

Read more
Latest articles

PR

27th October 2021

Royal Free London NHS Foundation Trust signs up to AI Award with Kheiron

“The study will provide evidence to help assess whether the use of AI in this instance could be a viable option,” said Dr William Teh, clinical lead with Royal Free London NHS ...

Read more
Latest articles

PR

27th October 2021

Kheiron, Gateshead Health Foundation NHS Trust Enter Research Agreement

Partnership marks significant step in the journey to build evidence base to demonstrate effectiveness and safety of AI in NHS breast cancer screening LONDON, 26 October 2021–&nbs...

Read more
1 2 3 7